BVS
vs
S&P 500
Over the past 12 months, BVS has significantly outperformed S&P 500, delivering a return of 96% compared to the S&P 500's 24% growth.
Stocks Performance
BVS vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JP |
Hoya Corp
TSE:7741
|
||
CH |
Alcon AG
SIX:ALC
|
||
DK |
Coloplast A/S
CSE:COLO B
|
||
US |
Align Technology Inc
NASDAQ:ALGN
|
||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
||
CA |
Bausch + Lomb Corp
NYSE:BLCO
|
||
UK |
ConvaTec Group PLC
LSE:CTEC
|
||
US |
Merit Medical Systems Inc
NASDAQ:MMSI
|
Performance Gap
BVS vs S&P 500
JP |
Hoya Corp
TSE:7741
|
||
CH |
Alcon AG
SIX:ALC
|
||
DK |
Coloplast A/S
CSE:COLO B
|
||
US |
Align Technology Inc
NASDAQ:ALGN
|
||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
||
CA |
Bausch + Lomb Corp
NYSE:BLCO
|
||
UK |
ConvaTec Group PLC
LSE:CTEC
|
||
US |
Merit Medical Systems Inc
NASDAQ:MMSI
|
Performance By Year
BVS vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JP |
Hoya Corp
TSE:7741
|
||
CH |
Alcon AG
SIX:ALC
|
||
DK |
Coloplast A/S
CSE:COLO B
|
||
US |
Align Technology Inc
NASDAQ:ALGN
|
||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
||
CA |
Bausch + Lomb Corp
NYSE:BLCO
|
||
UK |
ConvaTec Group PLC
LSE:CTEC
|
||
US |
Merit Medical Systems Inc
NASDAQ:MMSI
|
Competitors Performance
Bioventus Inc vs Peers
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
CA |
A
|
Advance Lithium Corp
XTSX:AALI
|
|
US |
G
|
GE Vernova LLC
NYSE:GEV
|
|
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
|
US |
Schlumberger NV
NYSE:SLB
|
||
US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
|
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
||
US |
R
|
Reddit Inc
NYSE:RDDT
|
|
CH |
G
|
Galderma Group AG
SIX:GALD
|
|
US |
Halliburton Co
NYSE:HAL
|
||
IN |
Jio Financial Services Ltd
NSE:JIOFIN
|
Bioventus Inc
Glance View
Bioventus, Inc. global medical technology company which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. The company is headquartered in Durham, North Carolina and currently employs 1,200 full-time employees. The company went IPO on 2021-02-11. The firm is focused on developing and commercializing clinically and minimally invasive treatments that engage and enhance the body’s natural healing process. The Company’s portfolio of products includes OA joint pain treatment and joint preservation, bone graft substitutes and minimally invasive fracture treatment. The OA joint pain treatment and joint preservation is focused on orthopedics. Its bone graft substitutes (BGSs) offers portfolio of products including human tissue allografts and synthetics. Its BGS products can be used in conjunction with any orthopedic fixation and spinal fusion implant. They are designed to improve bone fusion rates following spinal fusion and other orthopedic surgeries and reduce the need for using the patient’s own bone.